Nu Skin Enterprises, Inc.

Nu Skin Enterprises is a global direct sales personal care and nutritional supplement company with ageLOC as its flagship anti-aging platform — not a drug developer. Its 70 trials including 1 Phase 1 and 4 Phase 2 studies reflect clinical testing of its consumer beauty products under cosmeceutical research protocols. Insider buying at 1,276 transactions is active. Evaluate on direct sales distributor count, Mainland China revenue recovery, and Nu Skin's manufacturing beauty device (ageLOC) upgrade cycle.

<article class="bts-verified-summary" data-ticker="NUS">
<p>Nu Skin Enterprises, Inc. Common Stock (NUS) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.</p>
<p>NUS has 1 Form 4 insider filing recorded at the SEC in the past 30 days<sup><a href="#fn-1">[1]</a></sup>.</p>
<section class="sources" data-nosnippet aria-label="Sources"><h3>Sources</h3><ol><li id="fn-1">SEC EDGAR · 0001021561 (2026-04-11) <a href="https://efts.sec.gov/LATEST/search-index?q=%22NUS%22&amp;forms=4&amp;dateRange=custom&amp;startdt=2026-03-12&amp;enddt=2026-04-11" rel="nofollow noopener noreferrer">↗</a></li></ol></section>
</article>